Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Freag MS"'
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 17, Pp 1211-1231 (2023)
Hebatallah S Barakat,1 May S Freag,1 Sarah M Gaber,1 Affaf Al Oufy,2,3 Ossama Y Abdallah1 1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; 2Department of Material & Manufacturing Engineering, Faculty of Eng
Externí odkaz:
https://doaj.org/article/b81dc39def964789a5d4ae5c21749cc4
Publikováno v:
International Journal of Nanomedicine, Vol Volume 14, Pp 499-517 (2019)
Hadeer M Abdelaziz,1,2 Ahmed O Elzoghby,1,3–5 Maged W Helmy,1,6 Magda W Samaha,1,3 Jia-You Fang,7–9 May S Freag1,4,5,10 1Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; 2Depar
Externí odkaz:
https://doaj.org/article/6a9fd87574b445c8b7d1e4c735ce9fc6
Publikováno v:
International Journal of Nanomedicine, Vol Volume 11, Pp 4799-4818 (2016)
May S Freag,1 Yosra SR Elnaggar,1,2 Doaa A Abdelmonsif,3 Ossama Y Abdallah1 1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, 2Department of Pharmaceutics, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexa
Externí odkaz:
https://doaj.org/article/bfd70363c4d040febcf8fe716c29610d
Publikováno v:
International Journal of Nanomedicine, Vol 2013, Iss default, Pp 2385-2397 (2013)
May S Freag, Yosra SR Elnaggar, Ossama Y AbdallahDepartment of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptAbstract: Diosmin (DSN) is an outstanding phlebotonic flavonoid with a tolerable potential for the treatment of
Externí odkaz:
https://doaj.org/article/2e64a9ce22a147d1ba6f377e79021835
Autor:
Freag MS; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Investigative Toxicology, Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Cambridge, MA, USA., Mohammed MT; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Anatomical and Clinical Pathology Department, Tufts Medical Center, Boston, MA, USA., Kulkarni A; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA., Emam HE; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Maremanda KP; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, USA., Elzoghby AO; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Science advances [Sci Adv] 2024 Mar; Vol. 10 (9), pp. eadk3074. Date of Electronic Publication: 2024 Feb 28.
Autor:
Freag MS; Center for Engineered TherapeuticsDivision of Engineering in MedicineDepartment of MedicineBrigham and Women's HospitalHarvard Medical SchoolBostonMAUSA.; Division of Health Sciences and TechnologyHarvard-Massachusetts Institute of TechnologyMassachusetts Institute of TechnologyBostonMAUSA., Namgung B; Center for Engineered TherapeuticsDivision of Engineering in MedicineDepartment of MedicineBrigham and Women's HospitalHarvard Medical SchoolBostonMAUSA.; Division of Health Sciences and TechnologyHarvard-Massachusetts Institute of TechnologyMassachusetts Institute of TechnologyBostonMAUSA., Reyna Fernandez ME; Center for Engineered TherapeuticsDivision of Engineering in MedicineDepartment of MedicineBrigham and Women's HospitalHarvard Medical SchoolBostonMAUSA.; Division of Health Sciences and TechnologyHarvard-Massachusetts Institute of TechnologyMassachusetts Institute of TechnologyBostonMAUSA., Gherardi E; Unit of Immunology and General PathologyDepartment of Molecular MedicineUniversity of PaviaPaviaItaly., Sengupta S; Center for Engineered TherapeuticsDivision of Engineering in MedicineDepartment of MedicineBrigham and Women's HospitalHarvard Medical SchoolBostonMAUSA.; Division of Health Sciences and TechnologyHarvard-Massachusetts Institute of TechnologyMassachusetts Institute of TechnologyBostonMAUSA.; Dana Farber Cancer InstituteBostonMAUSA., Jang HL; Center for Engineered TherapeuticsDivision of Engineering in MedicineDepartment of MedicineBrigham and Women's HospitalHarvard Medical SchoolBostonMAUSA.
Publikováno v:
Hepatology communications [Hepatol Commun] 2020 Nov 29; Vol. 5 (2), pp. 217-233. Date of Electronic Publication: 2020 Nov 29 (Print Publication: 2021).
Autor:
Abdelaziz HM; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Pharmaceutics, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt., Elzoghby AO; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.; Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts 02139, United States., Helmy MW; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt., Abdelfattah EA; Medical Research Institute, Alexandria University, Alexandria 21521, Egypt., Fang JY; Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Taoyuan 333, Taiwan.; Research Center for Industry of Human Ecology and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Kweishan, Taoyuan 333, Taiwan.; Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan., Samaha MW; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt., Freag MS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.; Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts 02139, United States.; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Publikováno v:
ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2020 Feb 10; Vol. 6 (2), pp. 1030-1042. Date of Electronic Publication: 2020 Jan 30.
Autor:
Freag MS; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt., Torky AS; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt., Nasra MM; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt., Abdelmonsif DA; Department of Medical Biochemistry, Faculty of Medicine, Alexandria University, Egypt., Abdallah OY; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt.
Publikováno v:
Nanomedicine (London, England) [Nanomedicine (Lond)] 2019 Apr; Vol. 14 (8), pp. 931-954. Date of Electronic Publication: 2019 Mar 29.
Autor:
Elzoghby AO; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA. Electronic address: aelzoghby@bwh.harvard.edu., Freag MS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Publikováno v:
Drug discovery today [Drug Discov Today] 2019 Feb; Vol. 24 (2), pp. 361-363. Date of Electronic Publication: 2018 Nov 12.
Autor:
Zayed DG; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt., AbdElhamid AS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Freag MS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Division of Engineering in Medicine, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA., Elzoghby AO; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.; Division of Engineering in Medicine, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA.
Publikováno v:
Nanomedicine (London, England) [Nanomedicine (Lond)] 2019 Feb; Vol. 14 (3), pp. 225-228. Date of Electronic Publication: 2019 Jan 17.